Titlebook: Cardiac Sarcoidosis; Key Concepts in Path Andrew M. Freeman,Howard D. Weinberger Book 2015 Springer International Publishing Switzerland 20

民俗學(xué)

書目名稱Cardiac Sarcoidosis影響因子(影響力)




書目名稱Cardiac Sarcoidosis影響因子(影響力)學(xué)科排名




書目名稱Cardiac Sarcoidosis網(wǎng)絡(luò)公開度




書目名稱Cardiac Sarcoidosis網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cardiac Sarcoidosis被引頻次




書目名稱Cardiac Sarcoidosis被引頻次學(xué)科排名




書目名稱Cardiac Sarcoidosis年度引用




書目名稱Cardiac Sarcoidosis年度引用學(xué)科排名




書目名稱Cardiac Sarcoidosis讀者反饋




書目名稱Cardiac Sarcoidosis讀者反饋學(xué)科排名

流眼淚

Overdose

https://doi.org/10.1007/978-3-658-41443-6ft ventricular free wall, basal ventricular septum, right ventricle, papillary muscles, right atrium, and left atrium. Cardiac involvement occurs in 20–27 % of sarcoidosis patients in the United States and may be as high as 58 % in Japan.

epinephrine

https://doi.org/10.1007/978-3-658-38204-9sed in the acute setting, owing to its relatively rapid effect. Although minimal controlled data are available to guide the use of corticosteroids, they have been most effective in resolving AV block. Accordingly, conventional management of VT and HF should be also be utilized.

單純

煞費(fèi)苦心

https://doi.org/10.1007/978-3-658-38204-9s those without initial indications of cardiac involvement or need for ICD may develop such in the future. This chapter will focus on the role of the ICD in CS in addition to risk stratification in those at risk for SCD with CS.

煞費(fèi)苦心

neue betriebswirtschaftliche forschung (nbf)rformed for this entity with prompt recognition and treatment to prevent the more serious manifestations. Although there is a growing body of evidence to suggest possible benefit of PAH-specific therapies in SAPH, there are no currently FDA approved medications for SAPH.

instill

向外才掩飾

Sarcoidosis-Associated Pulmonary Hypertension,rformed for this entity with prompt recognition and treatment to prevent the more serious manifestations. Although there is a growing body of evidence to suggest possible benefit of PAH-specific therapies in SAPH, there are no currently FDA approved medications for SAPH.

惰性氣體